Tüüp : |
Ajaleht |
Interneti link : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=3891 |
|
Uurimisrühmad : |
Boston - Massachusetts Eye and Ear Infirmary, Harvard Medical School |
Autor : |
Robert M.C, Spurr-Michaud S, Frenette M, Young D, Gipson Ilene K, Dohlman Claes H. |
Pealkiri : |
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation. |
Publikatsioon : |
Int J Pharm Compound ;18, 5: 418-426. 2014 |
|
Tõendite tase : |
|
Füüsikaline stabiilsus : |
|
Keemiline püsivus : |
|
Muud meetodid : |
|
Kommentaarid : |
|
Ingredientide nimekiri
Infliximab
|
|
|
|
|
100 mg Remicade ® |
Naatriumkarboksümetüültselluloos |
50 mg |
Boorhape |
|
CaCl2 |
|
MgCl2 |
|
KCl |
|
Süstevesi |
>> 10 ml |
|
-20°C |
|
45 |
|
|
|
|
|
|
100 mg Remicade ® |
Naatriumkarboksümetüültselluloos |
50 mg |
Boorhape |
|
CaCl2 |
|
MgCl2 |
|
KCl |
|
Süstevesi |
>> 10 ml |
|
4°C |
|
45 |
|
|
|
|
|